Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT03985943. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of the study was to assess the efficacy and safety of nemolizumab after a 16-week treatment period in adult and adolescent subjects with moderate-to-severe atopic dermatitis (AD) not adequately controlled with topical treatments.
Study identification
- NCT ID
- NCT03985943
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 941 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 27, 2019 (Actual)
- Primary completion
- Dec 29, 2021 (Actual)
- Completion
- Aug 11, 2022 (Actual)
- Last update posted
- Aug 14, 2024
2019 – 2022
United States locations
- U.S. sites
- 57
- U.S. states
- 23
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site 8880 | North Little Rock | Arkansas | 72117 | — |
| Galderma Investigational Site 8578 | Cerritos | California | 90703 | — |
| Galderma Investigational Site 8636 | Fountain Valley | California | 92708 | — |
| Galderma Investigational Site 8888 | Fullerton | California | 92835 | — |
| Galderma Investigational Site 8686 | Lomita | California | 90717 | — |
| Galderma Investigational Site 8674 | Los Angeles | California | 90025 | — |
| Galderma Investigational Site 8125 | San Francisco | California | 94115 | — |
| Galderma Investigational Site 8895 | Santa Ana | California | 92703 | — |
| Galderma Investigational Site 8608 | Santa Monica | California | 90404 | — |
| Galderma Investigational Site 8897 | Brandon | Florida | 33511 | — |
| Galderma Investigational Site 8805 | Cape Coral | Florida | 33991 | — |
| Galderma Investigational Site 8902 | Doral | Florida | 33122 | — |
| Galderma Investigational Site 8804 | Hialeah | Florida | 33016 | — |
| Galderma Investigational Site 8711 | Jacksonville | Florida | 32256 | — |
| Galderma Investigational Site 8710 | Miami | Florida | 33126 | — |
| Galderma Investigational Site 8801 | Miami | Florida | 33145 | — |
| Galderma Investigational Site 8737 | Miami | Florida | 33174 | — |
| Galderma Investigational Site 8708 | Miami | Florida | 33176 | — |
| Galderma Investigational Site 8806 | Miami Lakes | Florida | 33014 | — |
| Galderma Investigational Site 8800 | Miami Lakes | Florida | 33016 | — |
| Galderma Investigational Site 8734 | Pembroke Pines | Florida | 33028 | — |
| Galderma Investigational Site 8744 | Macon | Georgia | 31217 | — |
| Galderma Investigational Site 8728 | Newnan | Georgia | 30263 | — |
| Galderma Investigational Site 8887 | Union City | Georgia | 30291 | — |
| Galderma Investigational Site 8890 | Blackfoot | Idaho | 83221 | — |
| Galderma Investigational Site 8819 | Nampa | Idaho | 83687 | — |
| Galderma Investigational Site 8571 | Skokie | Illinois | 60076 | — |
| Galderma Investigational Site 8712 | Skokie | Illinois | 60077 | — |
| Galderma Investigational Site 8142 | Indianapolis | Indiana | 46250 | — |
| Galderma Investigational Site 8771 | Louisville | Kentucky | 40241 | — |
| Galderma Investigational Site 8882 | Bangor | Maine | 04401 | — |
| Galderma Investigational Site 8743 | Ann Arbor | Michigan | 48109 | — |
| Galderma Investigational Site 8512 | Bay City | Michigan | 48706 | — |
| Galderma Investigational Site 8155 | Troy | Michigan | 48084 | — |
| Galderma Investigational Site 8748 | Ypsilanti | Michigan | 48197 | — |
| Galderma Investigational Site 8521 | Saint Joseph | Missouri | 64506 | — |
| Galderma Investigational Site 8718 | Missoula | Montana | 59808 | — |
| Galderma Investigational Site 8810 | Omaha | Nebraska | 68144 | — |
| Galderma Investigational Site 8740 | Henderson | Nevada | 89052 | — |
| Galderma Investigational Site 8242 | Brooklyn | New York | 11203 | — |
| Galderma Investigational Site 8620 | New York | New York | 10023 | — |
| Galderma Investigational Site 8279 | New York | New York | 10075 | — |
| Galderma Investigational Site 8648 | Wilmington | North Carolina | 28405 | — |
| Galderma Investigational Site 8702 | Bexley | Ohio | 43209 | — |
| Galderma Investigational Site 8595 | Dublin | Ohio | 43016 | — |
| Galderma Investigational Site 8206 | Norman | Oklahoma | 73071 | — |
| Galderma Investigational Site 8857 | Oklahoma City | Oklahoma | 73118 | — |
| Galderma Investigational Site 8255 | Philadelphia | Pennsylvania | 19103 | — |
| Galderma Investigational Site 8802 | Plymouth Meeting | Pennsylvania | 19462 | — |
| Galderma Investigational Site 8736 | Charleston | South Carolina | 29425 | — |
| Galderma Investigational Site 8818 | Rapid City | South Dakota | 57702 | — |
| Galderma Investigational Site 8133 | Arlington | Texas | 76011 | — |
| Galderma Investigational Site 8238 | Dallas | Texas | 75230 | — |
| Galderma Investigational Site 8827 | Dripping Springs | Texas | 78620 | — |
| Galderma Investigational Site 8664 | Frisco | Texas | 75034 | — |
| Galderma Investigational Site 8042 | Houston | Texas | 77056 | — |
| Galderma Investigational Site 8862 | Fairfax | Virginia | 22031 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 117 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03985943, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 14, 2024 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03985943 live on ClinicalTrials.gov.